Clean Science & Technology executed a significant block trade on the National Stock Exchange (NSE), marking a notable institutional transaction in the specialty chemicals sector.

Block Trade Details

The transaction involved substantial volume and value, reflecting institutional interest in the company's shares.

Market Significance

Block trades are large-volume transactions typically executed by institutional investors, mutual funds, or other large stakeholders. These trades are conducted outside the regular market order book to minimize market impact and ensure efficient price discovery for substantial volumes.

The execution of this block trade at Rs. 831.00 per share indicates institutional activity in Clean Science and Technology Ltd.'s stock. Such transactions often reflect portfolio rebalancing, strategic exits, or new institutional entries into the stock.

About the Transaction

The Rs. 16.59 crore transaction represents a significant value exchange in the specialty chemicals space. Block trades of this magnitude typically require careful execution to ensure minimal market disruption while providing the necessary liquidity for large-volume requirements.

Clean Science & Technology Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showing a decline in both revenue and profitability compared to the previous year. The specialty chemicals manufacturer also declared an interim dividend for shareholders during its board meeting held on January 31, 2026.

Financial Performance Overview

The company's financial performance for Q3FY26 reflected challenging market conditions with significant year-on-year declines across key metrics:

The company's total income for the quarter decreased to ₹1,943.29 million from ₹2,361.53 million in Q3FY25, representing a decline of 17.7%. Other income increased to ₹88.39 million from ₹45.96 million, providing some offset to the operational revenue decline.

EBITDA Performance Analysis

The company's EBITDA performance showed significant pressure during Q3FY26, reflecting the challenging operating environment:

The EBITDA decline of 26.6% to ₹722 million from ₹984 million in Q3FY25 indicates operational challenges beyond just revenue contraction. The EBITDA margin compression to 33% from 40.80% suggests increased cost pressures and reduced operational efficiency during the quarter.

Consolidated Performance Results

On a consolidated basis, Clean Science & Technology reported revenue from operations of ₹2,196.70 million for Q3FY26, compared to ₹2,408.16 million in Q3FY25. The consolidated performance showed similar trends to standalone results:

The consolidated net profit of ₹459.00 million represented a 30% decline from ₹656.00 million in the corresponding quarter of the previous year, reflecting the challenging operating environment across the group.

Management Commentary on Market Challenges

During the earnings conference call held on January 31, 2026, Executive Director and Promoter Siddharth Sikchi outlined the challenging business environment that continued from Q2 into Q3. The company faced muted customer offtake, pricing pressure, and tariff-related uncertainties, along with incremental capacities from competitors, especially in China.

The management emphasized that the revenue decline was primarily volume-driven, with 19% attributed to volume decline and only 2% to price realization issues on a year-on-year basis.

HALS Business Shows Strong Growth

Despite overall challenges, the Hindered Amine Light Stabilizers (HALS) business delivered robust performance with 55% year-on-year growth, driven by favorable product mix and higher contribution from cost-efficient, higher-derivatized HALS polymers:

The subsidiary Clean Fino Chem Limited achieved EBITDA breakeven during the quarter, marking a significant milestone for the HALS business segment.

Capex Updates and New Product Commercialization

The company successfully commercialized its hydroquinone and catechol plant in December, with customer trials currently ongoing. This development is expected to provide immediate margin benefits across downstream products:

The management indicated that Performance Chemical 1 is expected to generate revenue of ₹260 crores at 80% capacity utilization, revised down from earlier estimates of ₹320 crores due to current market pricing conditions.

Board Meeting Outcomes and Dividend Declaration

The board of directors, in their meeting held on January 31, 2026, approved the unaudited standalone and consolidated financial results and declared an interim dividend of ₹2.00 per equity share (200%) for the financial year 2025-26:

The dividend will be paid to shareholders whose names appear in the company's register of members as on February 6, 2026. The board also welcomed two new independent directors, Mr. Raj Kamal and Mrs. Pallavi Gokhale, as successors to retiring independent directors.

Earnings Call Recording and Regulatory Compliance

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has submitted the complete transcript of the Q3 FY26 Earnings Conference Call held on January 31, 2026. The detailed transcript provides comprehensive insights into management's perspective on current market conditions and future outlook:

The earnings call transcript has been made available to stakeholders and investors for comprehensive understanding of the company's financial performance, operational challenges, and strategic initiatives during these challenging market conditions.